About CardioPrecision
CardioPrecision is a company based in Glasgow (United Kingdom) founded in 2007 by Fraser Sutherland and Ying Sutherland. The company has 3 employees as of July 31, 2021. CardioPrecision offers products and services including CoreVista® Retractor, CoreVista® with sutureless valves, CoreVista® for TAVR, CoreVista® for EVH, and CoreVista® Accessories. CardioPrecision operates in a competitive market with competitors including Corinth MedTech, Atraverse Medical, Saint Medical, ValTech Lifesciences and Zhitong Technology, among others.
- Headquarter Glasgow, United Kingdom
- Employees 3 as on 31 Jul, 2021
- Founders Fraser Sutherland, Ying Sutherland
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Cardioprecision Ltd
- Date of Incorporation 31 May, 2007
- Jurisdiction GLASGOW, UNITED KINGDOM
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Scottish Enterprise
& 3 more
-
Employee Count
3
as on Jul 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of CardioPrecision
CardioPrecision offers a comprehensive portfolio of products and services, including CoreVista® Retractor, CoreVista® with sutureless valves, CoreVista® for TAVR, CoreVista® for EVH, and CoreVista® Accessories.
Device for minimally invasive cardiothoracic surgery through short incisions.
Technology for implanting valves in aortic position with magnified views.
Used in hybrid rooms for direct aortic transcatheter procedures.
Facilitates harvesting of vessels for bypass grafting surgeries.
Components providing illumination and drapes for operative fields.
People of CardioPrecision
Unlock access to complete
Unlock access to complete
Funding Insights of CardioPrecision
Investors in CardioPrecision
CardioPrecision has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Scottish Enterprise, London & Scottish Investments and Discovery Investment Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Asset management and property development services are provided across the UK.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Business development and leadership training programs are offered to companies.
|
Locked | Locked | Locked |
Investor details for CardioPrecision
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by CardioPrecision
Investment portfolio details for CardioPrecision
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - CardioPrecision
Detailed financials for CardioPrecision
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cardioprecision Comparisons
Peer comparison for CardioPrecision
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of CardioPrecision
CardioPrecision operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Corinth MedTech, Atraverse Medical, Saint Medical, ValTech Lifesciences and Zhitong Technology, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of resectoscope for surgical procedure and fluid management solution
|
|
| Locked | Locked | Locked |
Next-generation tools for left-heart access are developed for cardiac treatments.
|
|
| Locked | Locked | Locked |
Medical devices for invasive cardiovascular surgery are developed.
|
|
| Locked | Locked | Locked |
Medical devices for cardiac surgeries are provided by ValTech Lifesciences.
|
|
| Locked | Locked | Locked |
Developer of surgical devices for ophthalmic indications
|
Detailed competitors of CardioPrecision
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cardioprecision
Complete news archive for CardioPrecision
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CardioPrecision
CardioPrecision was founded in 2007 and raised its 1st funding round 15 years after it was founded.
CardioPrecision is headquartered in Glasgow, United Kingdom. It is registered at Glasgow, Scotland, United Kingdom.
Ying Sutherland is the current CEO of CardioPrecision. They have also founded this company.
As of Jul 31, 2021, the latest employee count at CardioPrecision is 3.
Founded in 2007 and based in Glasgow, United Kingdom, CardioPrecision operates in the medical devices sector. Single-use CoreVista retractors and related accessories are developed by the company to enable minimally invasive cardiothoracic surgery. Procedures are facilitated through a short incision in the necks skin crease, targeting less invasive treatments for structural heart disease.
CardioPrecision's top competitors include Atraverse Medical, Zhitong Technology and Auflows CardioTech.
CardioPrecision offers CoreVista® Retractor, CoreVista® with sutureless valves, CoreVista® for TAVR, CoreVista® for EVH, and CoreVista® Accessories.
CardioPrecision has 4 investors. Key investors include Scottish Enterprise, London & Scottish Investments, Discovery Investment Fund, and InnoScot.